Wanda’s story: A heart at high risk
January 1, 2018
Sisters Wanda Taylor and Liz Brantley shared everything,
including a family history of early, and often fatal, heart attacks. But one thing they didn’t share was a tolerance for statins. For Wanda, being unable to take cholesterol-lowering drugs meant she was never far away from a cardiac event, and never able to begin the healing process.
At Liz’s suggestion, Wanda began seeing doctors at UT Southwestern, where they started her on a new drug called Repatha. Based on a discovery made by UT Southwestern Drs. Helen Hobbs and Jonathan Cohen, Repatha is a cholesterol-lowering drug for statin intolerant patients like Wanda. She saw an immediate and dramatic improvement in her cholesterol numbers. And for her sister, Liz, that’s when the healing really began.
She saw an immediate and dramatic improvement in her cholesterol numbers.
With her sister’s cholesterol under control, Liz felt a weight lifting for the first time in her life. The condition that had taken two brothers, and led to countless medical procedures for the rest of her family, was replaced by a more certain future. A future defined by optimism made possible by a medical breakthrough. And for Wanda, the most important part of this story is the one yet to be written with her sister, including what they were doing immediately following this interview: “Margaritas. We’re going to get margaritas.”
Dr. Rohatgi’s perspective: Advanced heart care with a twist
Discover how personalized therapy reduced Wanda’s heart attack risk.
Leaders in Heart and Vascular Care
Combining attentive, compassionate care with our extensive clinical and research resources, UT Southwestern's cardiology experts and vascular specialists deliver individualized care within pre-eminent health care facilities.